Sanofi gets se­ri­ous in Chi­na with plans to hire 300 for $76M R&D site in Cheng­du

Sev­er­al big phar­mas have re­cent­ly shut­tered their re­search op­er­a­tions in Chi­na, but Sanofi is ap­par­ent­ly buck­ling down in the re­gion with a new glob­al R&D hub. The com­pa­ny is hir­ing 300 peo­ple in Cheng­du, Chi­na to run a tech-fo­cused op­er­a­tion that’s meant to speed up analy­sis of its clin­i­cal tri­als.

Sanofi is in­vest­ing €66 mil­lion ($76.6 mil­lion) in the hub and will have it ful­ly staffed by 2020. The R&D cen­ter is sup­posed to sup­port Sanofi’s drug de­vel­op­ment by man­ag­ing glob­al mul­ti-cen­ter clin­i­cal tri­al da­ta and files. The com­pa­ny says it will “take ad­van­tage of lo­cal tal­ents” to strength­en Sanofi’s dig­i­tal ca­pa­bil­i­ties, speed­ing up tri­als re­sults.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER